Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer

scientific article

Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1007307755
P356DOI10.1038/ONC.2009.409
P932PMC publication ID2829108
P698PubMed publication ID19935720
P5875ResearchGate publication ID40029023

P2093author name stringZ Lin
P Yin
M O'Halloran
S E Bulun
S Reierstad
G M Mutlu
E K Pearson
V J S Coon
P2860cites workRole of estrogen receptor beta in estrogen actionQ24290841
From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen responseQ24313831
Identification of ERF-1 as a member of the AP2 transcription factor familyQ24314887
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situQ25257848
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-deltaQ28215162
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1Q28260929
The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun proteinQ33561391
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.Q34522572
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation.Q34712217
A glance at adenosine receptors: novel target for antitumor therapyQ35556102
Adenosine regulation of alveolar fluid clearanceQ35676784
A1 adenosine receptors play an essential role in protecting the embryo against hypoxiaQ35834361
Estrogen-receptor biology: continuing progress and therapeutic implicationsQ36065443
Are aromatase inhibitors superior to antiestrogens?Q36110134
Estrogen signaling and prediction of endocrine therapyQ36307432
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancerQ37288929
Current controversies in extended adjuvant endocrine therapy for early breast cancerQ37289138
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancerQ38301651
AP2 transcription factors regulate expression of CRABPII in hormone responsive breast carcinomaQ38306274
Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells.Q40095142
Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.Q40198514
Stable knockdown of estrogen receptor alpha by vector-based RNA interference suppresses proliferation and enhances apoptosis in breast cancer cellsQ40270203
RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosisQ40350122
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.Q40470094
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell linesQ40483284
Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genesQ40498615
An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferationQ40626058
Cancer statistics, 1999.Q40817780
The 3'-untranslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnoverQ40864729
PD 116,948, a highly selective A1 adenosine receptor antagonistQ41479175
Sensitization of visceral afferents to bradykinin in rat jejunum in vitroQ42480612
Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases.Q42522011
Endogenous activation of adenosine A1 receptors promotes post-ischemic electrocortical burst suppression.Q44540086
Early renal post-ischaemic tissue damage and dysfunction with contribution of A1-adenosine receptor activation in rat.Q46126305
Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancerQ46610637
Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injuryQ46668123
Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptorQ57255422
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected CellsQ60568779
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D)Q70239986
Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue cultureQ70306908
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cellsQ71124075
The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cellsQ77835923
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypesQ83297557
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)1114-1122
P577publication date2009-11-23
P1433published inOncogeneQ1568657
P1476titleAdenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer
P478volume29

Reverse relations

cites work (P2860)
Q39148961Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.
Q36191587Aromatase, breast cancer and obesity: a complex interaction
Q30981105Combined Analysis of SNP Array Data Identifies Novel CNV Candidates and Pathways in Ependymoma and Mesothelioma
Q49412232Estrogen stimulates adenosine receptor expression subtypes in human breast cancer MCF-7 cell line
Q24319134Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells
Q37775889Extracellular adenosine triphosphate and adenosine in cancer.
Q38870205Extracellular purines, purinergic receptors and tumor growth.
Q55163381Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats.
Q34038901Immunity, inflammation and cancer: a leading role for adenosine
Q90317840Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
Q39224357Role of adenosine signaling in the pathogenesis of breast cancer.
Q57460030Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model
Q93062525Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Q37721517The Role of Adenosine Signaling in Headache: A Review
Q37626856The complex nature of oestrogen signalling in breast cancer: enemy or ally?
Q38744576The effect of adenosine A1 receptor agonist and antagonist on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line
Q98185640Tumorigenesis and Progression As A Consequence of Hypoxic TME:A Prospective View upon Breast Cancer Therapeutic Targets

Search more.